Moderna's mRNA Flu Vaccine, mFLUSIVA, Gains FDA Approval for Adults 50+
Moderna has received Food and Drug Administration approval for its mRNA-based flu vaccine, mFLUSIVA, for individuals aged 50 and older, despite a contentious review process.
Archive
Moderna has received Food and Drug Administration approval for its mRNA-based flu vaccine, mFLUSIVA, for individuals aged 50 and older, despite a contentious review process.
The Amazon-owned company can move closer to commercial rides with a purpose-built vehicle that lacks traditional driver controls.
Apple Upgrade replaces two existing U.S. payment programs and lets eligible customers return, buy or exchange a device at the end of the lease.
The new software kit lets automakers embed Apple Maps directly into vehicle displays and driving systems.
The subscription update separates mainstream, professional and higher-compute access as Google expands Gemini across its products.
New developer primitives address memory, subagents, execution and recoverable long-running work.